6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: June 13, 2022
Period of Report: June 13, 2022
Accession Number: 0001213900-22-032375

View Document ↗ View on SEC.gov ↗